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Both are one in origin
and different only in name.
In its unity it is called the secret.
The secret’s still deeper secret
is the gateway through which all miracles emerge.
—Dao De Jing (Part I)
No other work of Chinese literature has attracted as much attentionas Lao Zi’s Dao De Jing, which has been translated more oftenthan any other book except the Bible. The term Tai Ji (the primalbeginning), possibly first defined by Lao Zi at the end of theseventh century BC, played a major role in ancient Chinese phil-osophical thinking. The symbol of Tai Ji is the “Yin-Yang fish,” so
named because of the matching fish-shaped design (Figure 1), in which the white
half of the circle containing a black dot stands for the “positive, masculine, warm”
principle (Yang), and the complementary black half of the circle symbolizes the
“negative, feminine, cold” principle (Yin). This figure has been used in endless
representations of the coexisting positive and negative forces being within each
other. As rationalized by Lao Zi, the 2 complementary principles of Yin and Yang
are the driving forces for the formation and evolution of all things in nature. This is
probably what was meant by the “great secret of the unity of existence and
non-existence.”
Lao Zi’s theory might still have countless interpretations 3000 years later.
Interestingly enough, it also fits well with our current understanding of the inflam-
matory response after cardiac operations.
In this issue of the Journal, Kubala and colleagues1 compared the cytokine
responses and neutrophil oxidative stress in patients undergoing heart transplanta-
tion versus other standard cardiac surgical procedures on cardiopulmonary bypass.
At first glance, one might wonder whether they were comparing apples with
oranges. There are several important differences between the 2 study groups of
patients. For instance, the duration of cardiac ischemia in the transplant group was
much longer, and the transplant recipients received immunosuppressive therapy, just
to name 2 of these differences. Nonetheless, we agree with Kubala and colleagues
that to explore the relationship between myocardial ischemia and reperfusion and
the inflammatory response, transplant operations provide a unique model in the
clinical setting.
There are some subtle but significant differences in the protocol of the current
study compared with the one carried out in Brussels a few years ago,2 and these
must be borne in mind when we examine the results. In particular, the numerous
intergroup variables made it difficult to interpret the postoperative day 7 data in the
current study. No samples were collected beyond 24 hours after aortic declamping
in the Brussels study to minimize the unavoidable influence of immunosuppressive
therapy.2 As far as the cytokine response is concerned, Kubala and colleagues1
nicely confirmed the previous findings,2,3 although in the current study the levels of
interleukin (IL) 6 and IL-8 shortly after reperfusion appeared to be lower, whereas
IL-10 levels were greater, than those in the Brussels study.2 It should be noted that
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Kubala and colleagues1 administered the first dose of meth-
ylprednisolone before the transplant procedure, whereas the
transplant recipients in Brussels received their first dose of
methylprednisolone 90 minutes after aortic declamping.2
We have previously demonstrated that the timing of steroid
administration could alter the release of cytokines remark-
ably,3 which might explain the observed discrepancies.
Apart from the positive correlation between IL-6 and
IL-8 in all patients, probably a more important finding in the
study by Kubala and colleagues1 is the specific influence of
immunosuppressive therapy on lipid peroxidation and
phagocyte activity after the transplant procedure. Unfortu-
nately, they did not provide data comparing the extent of
myocardial injury (eg, postoperative release of cardiac tro-
ponin I). The question thus remains whether pharmacologic
intervention, such as steroid pretreatment, is beneficial to
patients undergoing cardiac operations3 or whether blocking
IL-6 or IL-8 could lead to improved myocardial preserva-
tion, as proposed previously.4,5
In search for answers, we might learn something from
yet another kind of apples-versus-oranges comparison,
namely the studies on coronary artery bypass grafting
(CABG) with or without cardiopulmonary bypass. It is now
widely accepted that, compared with conventional CABG,
off-pump CABG is associated with a reduced inflammatory
response, which might result in a significantly lesser degree
of postoperative myocardial injury.6-8 However, IL-6 pro-
duction after these 2 approaches has been repeatedly deter-
mined to be similar.6,9-11 In contrast, IL-8 production during
and after conventional CABG was significantly greater than
that after the off-pump procedure,6,10,12 and IL-8 level has
been strongly correlated with postoperative release of car-
diac troponin I.6 Meanwhile, the release of an anti-inflam-
matory cytokine, IL-10, is almost proportional to the levels
of IL-8 during either on-pump13 or off-pump CABG.6
We are beginning to appreciate that a low-grade inflam-
matory response within the physiologic range is actually
protective to the body. Some cytokines, such as IL-6, might
even carry both proinflammatory and anti-inflammatory
properties.13 Indeed, one might get overwhelmed by the
high complexity of the body responses to injury. The more
we know about inflammatory responses, the more complex
they seem to become, and the further we appear to be from
the true understanding of the process. Nevertheless, for
myocardial injury after cardiac operations, accumulating
evidence now indicates the following: (1) IL-6 and IL-8
might not exert equally important effects, and (2) instead of
blocking each individual mediator, maintaining a balance
between proinflammatory and anti-inflammatory responses
might be more crucial.
One could imagine the concept of Tai Ji in the body’s
inflammatory response to injury. Nature has created in us a
highly sophisticated system with various intrinsic counter-
acting forces to restore homeostasis once the system is
disturbed. Pathology often represents an exaggeration of the
physiologic response in an attempt to re-establish such
balance. To focus all our attention on Yin and ignore Yang,
or vice versa, might well turn out not to be the ideal
approach one should take.
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